Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus.

Sarra M, Monteleone G.

J Biomed Biotechnol. 2010;2010:294582. doi: 10.1155/2010/294582. Epub 2010 Jun 28. Review.

PMID:
20652041
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prostaglandin E2-mediated dysregulation of proinflammatory cytokine production in pristane-induced lupus mice.

Chae BS, Shin TY, Kim DK, Eun JS, Leem JY, Yang JH.

Arch Pharm Res. 2008 Apr;31(4):503-10. doi: 10.1007/s12272-001-1185-6. Epub 2008 May 1.

PMID:
18449509
[PubMed - indexed for MEDLINE]
3.

Cytokine panel and histopathological aspects in the systemic lupus erythematosus.

Avrămescu C, Biciuşcă V, Dăianu T, Turculeanu A, Bălăşoiu M, Popescu SN, Ionete O, Simionescu C.

Rom J Morphol Embryol. 2010;51(4):633-40.

PMID:
21103619
[PubMed - indexed for MEDLINE]
Free Article
4.

Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus.

Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW.

Clin Exp Immunol. 2010 Jan;159(1):11-22. doi: 10.1111/j.1365-2249.2009.04036.x. Epub 2009 Oct 16.

PMID:
19843090
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.

Peng H, Wang W, Zhou M, Li R, Pan HF, Ye DQ.

Clin Rheumatol. 2013 Sep;32(9):1255-66. doi: 10.1007/s10067-013-2294-3. Epub 2013 May 25. Review.

PMID:
23708831
[PubMed - indexed for MEDLINE]
6.

Interleukin-17 and systemic lupus erythematosus: current concepts.

Nalbandian A, Crispín JC, Tsokos GC.

Clin Exp Immunol. 2009 Aug;157(2):209-15. doi: 10.1111/j.1365-2249.2009.03944.x. Review.

PMID:
19604260
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Do cytokines play a role in systemic lupus erythematosus?

Singh AK.

J R Coll Physicians Lond. 1992 Oct;26(4):374-6. Review.

PMID:
1432876
[PubMed - indexed for MEDLINE]
8.

Therapeutic potential of IL-27 in systemic lupus erythematosus.

Pan HF, Tao JH, Ye DQ.

Expert Opin Ther Targets. 2010 May;14(5):479-84. doi: 10.1517/14728221003769911. Review.

PMID:
20350048
[PubMed - indexed for MEDLINE]
9.

B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.

al-Janadi M, Raziuddin S.

J Rheumatol. 1993 Nov;20(11):1885-91.

PMID:
7508509
[PubMed - indexed for MEDLINE]
10.

A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice.

Bubier JA, Sproule TJ, Foreman O, Spolski R, Shaffer DJ, Morse HC 3rd, Leonard WJ, Roopenian DC.

Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1518-23. doi: 10.1073/pnas.0807309106. Epub 2009 Jan 21.

PMID:
19164519
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

T- and B-cell abnormalities in systemic lupus erythematosus.

Nagy G, Koncz A, Perl A.

Crit Rev Immunol. 2005;25(2):123-40. Review.

PMID:
15952933
[PubMed - indexed for MEDLINE]
12.

B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice.

Scapini P, Lamagna C, Hu Y, Lee K, Tang Q, DeFranco AL, Lowell CA.

Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):E823-32. doi: 10.1073/pnas.1107913108. Epub 2011 Sep 12.

PMID:
21911371
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

B-cell-targeted therapy for systemic lupus erythematosus.

Sabahi R, Anolik JH.

Drugs. 2006;66(15):1933-48.

PMID:
17100405
[PubMed - indexed for MEDLINE]
14.

Cytokines play a central role in the pathogenesis of systemic lupus erythematosus.

Singh AK.

Med Hypotheses. 1992 Dec;39(4):356-9.

PMID:
1494323
[PubMed - indexed for MEDLINE]
15.

Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus.

Li J, Pan HF, Cen H, Tian J, Ma Y, Tao JH, Ye DQ.

Mol Biol Rep. 2011 Aug;38(6):4077-81. doi: 10.1007/s11033-010-0527-y. Epub 2010 Nov 24. Review.

PMID:
21107711
[PubMed - indexed for MEDLINE]
16.

IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression.

Herber D, Brown TP, Liang S, Young DA, Collins M, Dunussi-Joannopoulos K.

J Immunol. 2007 Mar 15;178(6):3822-30.

PMID:
17339481
[PubMed - indexed for MEDLINE]
Free Article
17.

Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity.

Sabry A, Sheashaa H, El-Husseini A, Mahmoud K, Eldahshan KF, George SK, Abdel-Khalek E, El-Shafey EM, Abo-Zenah H.

Cytokine. 2006 Aug;35(3-4):148-53. Epub 2006 Oct 5.

PMID:
17027280
[PubMed - indexed for MEDLINE]
18.
19.

Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.

Kawamoto M, Harigai M, Hara M, Kawaguchi Y, Tezuka K, Tanaka M, Sugiura T, Katsumata Y, Fukasawa C, Ichida H, Higami S, Kamatani N.

Arthritis Res Ther. 2006;8(3):R62. Epub 2006 Mar 22.

PMID:
16563187
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.

Enghard P, Langnickel D, Riemekasten G.

Scand J Rheumatol. 2006 May-Jun;35(3):209-16.

PMID:
16766368
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk